Is there an ideal animal model for SARS?
- PMID: 16759866
- PMCID: PMC7119110
- DOI: 10.1016/j.tim.2006.05.007
Is there an ideal animal model for SARS?
Abstract
The outbreak of severe acute respiratory syndrome (SARS) in 2003 was controlled by public health measures at a time when specific interventions such as antiviral drugs, vaccines and immunotherapy were not available. Since then, several animal models have been developed for the study of SARS and, although no model replicates the human disease in all aspects, the use of animal models for SARS has led to the establishment of several important principles for vaccine and immunotherapy. Consistency and reproducibility of findings in a given model must be demonstrated to establish the superiority of one model over others. Here, we suggest aspects of an ideal animal model for studies of SARS pathogenesis and vaccine development and present our assessment of the strengths and limitations of the current animal models for SARS.
Similar articles
-
Severe acute respiratory syndrome vaccine efficacy in ferrets: whole killed virus and adenovirus-vectored vaccines.J Gen Virol. 2008 Sep;89(Pt 9):2136-2146. doi: 10.1099/vir.0.2008/001891-0. J Gen Virol. 2008. PMID: 18753223
-
Animal models and antibody assays for evaluating candidate SARS vaccines: summary of a technical meeting 25-26 August 2005, London, UK.Vaccine. 2006 Nov 30;24(49-50):7056-65. doi: 10.1016/j.vaccine.2006.07.009. Epub 2006 Jul 18. Vaccine. 2006. PMID: 16930781 Free PMC article.
-
Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets.Lancet. 2004 Jun 26;363(9427):2139-41. doi: 10.1016/S0140-6736(04)16506-9. Lancet. 2004. PMID: 15220038 Free PMC article.
-
[Recent developments in SARS vaccine studies].Mikrobiyol Bul. 2010 Jul;44(3):505-17. Mikrobiyol Bul. 2010. PMID: 21064002 Review. Turkish.
-
Studies of severe acute respiratory syndrome coronavirus pathology in human cases and animal models.Vet Pathol. 2010 Sep;47(5):881-92. doi: 10.1177/0300985810378760. Epub 2010 Jul 27. Vet Pathol. 2010. PMID: 20664013 Review.
Cited by
-
Antigen-Specific T Cells and SARS-CoV-2 Infection: Current Approaches and Future Possibilities.Int J Mol Sci. 2022 Dec 1;23(23):15122. doi: 10.3390/ijms232315122. Int J Mol Sci. 2022. PMID: 36499448 Free PMC article. Review.
-
Animal models for COVID-19: advances, gaps and perspectives.Signal Transduct Target Ther. 2022 Jul 7;7(1):220. doi: 10.1038/s41392-022-01087-8. Signal Transduct Target Ther. 2022. PMID: 35798699 Free PMC article. Review.
-
Psychosis during the COVID-19 pandemic: A systematic review of case reports and case series.J Psychiatr Res. 2022 Sep;153:37-55. doi: 10.1016/j.jpsychires.2022.06.041. Epub 2022 Jul 1. J Psychiatr Res. 2022. PMID: 35797814 Free PMC article. Review.
-
Animal models for SARS-CoV-2 and SARS-CoV-1 pathogenesis, transmission and therapeutic evaluation.World J Virol. 2022 Jan 25;11(1):40-56. doi: 10.5501/wjv.v11.i1.40. World J Virol. 2022. PMID: 35117970 Free PMC article. Review.
-
The Trend of CRISPR-Based Technologies in COVID-19 Disease: Beyond Genome Editing.Mol Biotechnol. 2023 Feb;65(2):146-161. doi: 10.1007/s12033-021-00431-7. Epub 2022 Jan 29. Mol Biotechnol. 2023. PMID: 35091986 Free PMC article. Review.
References
-
- Drosten C. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N. Engl. J. Med. 2003;348:1967–1976. - PubMed
-
- Ksiazek T.G. A novel coronavirus associated with severe acute respiratory syndrome. N. Engl. J. Med. 2003;348:1953–1966. - PubMed
-
- Poutanen S.M. Identification of severe acute respiratory syndrome in Canada. N. Engl. J. Med. 2003;348:1995–2005. - PubMed
-
- Guan Y. Isolation and characterization of viruses related to the SARS coronavirus from animals in Southern China. Science. 2003;302:276–278. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous